What are the microscopic findings of myocardial infarction, including the cells involved?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 29, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Microscopic Findings of Myocardial Infarction

Myocardial infarction is characterized pathologically by coagulation necrosis and/or contraction band necrosis, with polymorphonuclear leukocytes defining acute infarction, followed by mononuclear cells and fibroblasts during healing, and ultimately scar tissue formation. 1

Fundamental Pathologic Features

Cell death occurs primarily through oncosis (coagulative necrosis) as the dominant mechanism, with apoptosis playing a lesser but significant role. 1, 2 Both forms of cell death coexist in every myocardial infarction, though their relative proportions and timing differ. 3

Key Distinguishing Features:

  • Necrotic myocytes rapidly disintegrate and lose membrane integrity, evoking acute inflammation 3
  • Apoptotic myocytes retain membrane integrity and do not trigger acute inflammation 3
  • Complete necrosis of all at-risk myocardial cells requires at least 2-4 hours or longer, depending on collateral circulation, intermittent occlusion patterns, and individual oxygen demand 1, 2

Temporal Evolution: The Microscopic Timeline

Hyperacute Phase (<6 hours)

  • Waviness of myocardial fibers may be the only detectable microscopic finding in very early sudden death 1
  • Minimal or no polymorphonuclear leukocytes are present if death occurs within 6 hours of onset 1
  • Standard microscopic examination requires approximately 6 hours before myocardial necrosis becomes identifiable 1, 2
  • Apoptosis appears as the early and predominant form of cell death, visible within hours before coagulative necrosis becomes apparent 4
  • Apoptotic changes are particularly prominent in myocytes containing contraction bands, which occur predominantly in reperfused regions 4

Acute Phase (6 hours to 7 days)

The presence of polymorphonuclear leukocytes is the defining histologic feature of acute myocardial infarction. 1 This inflammatory infiltrate serves to clear dead cells and matrix debris from the injured myocardium. 5, 6

Cellular Components:

  • Polymorphonuclear leukocytes (neutrophils) dominate the acute inflammatory response 1
  • Necrotic cardiomyocytes release danger signals (interleukin-1α and RNA) that trigger the inflammatory cascade 5
  • Coagulative necrosis extends from subendocardium to subepicardium in a "wavefront" pattern over 2-4 hours 2

Healing Phase (7 to 28 days)

The presence of mononuclear cells and fibroblasts with absence of polymorphonuclear leukocytes characterizes healing infarction. 1

Cellular Components:

  • Macrophages exhibit significant heterogeneity and phenotypic plasticity, orchestrating the reparative response 5
  • Phagocytosis of apoptotic cells occurs through engulfment by either neighboring myocytes or macrophages (predominantly the latter) 3
  • Inhibitory lymphocytes play a crucial role in negative regulation of inflammation by modulating macrophage and fibroblast phenotype 5
  • Fibroblasts begin converting to myofibroblasts under the influence of transforming growth factor-β and renin-angiotensin-aldosterone system activation 6
  • Mononuclear inflammatory cells replace neutrophils 1

Healed Phase (≥29 days)

Scar tissue without cellular infiltration manifests as the healed infarction. 1 The entire process leading to a healed infarction usually takes at least 5-6 weeks. 1, 2

Special Microscopic Features with Reperfusion

Reperfusion significantly alters the microscopic appearance, producing myocytes with prominent contraction bands and large quantities of extravasated erythrocytes. 1, 2

  • Contraction bands become prominent as calcium rushes into dying cells, causing hypercontraction of myofibrils 2
  • This pattern differs markedly from non-reperfused infarction and must be recognized to avoid misinterpretation 1
  • Apoptosis is accelerated in reperfused myocardium, appearing primarily in cells with contraction bands 4

Critical Diagnostic Pitfalls

Timing Discordance

Clinical and electrocardiographic timing may not correspond exactly with pathological timing. 1, 7 The ECG may show evolving ST-T changes and biomarkers may remain elevated when pathologically the infarction is already in the healing phase. 1, 7

Underestimation of Infarct Size

Because apoptotic cells retain membrane integrity, enzymatic diagnosis based on intracellular enzyme release (troponin, CK-MB) reflects only necrosis. 3 Measurement of any intracellular enzyme consequently always underestimates the extent of myocardial infarction, often by a large margin, as apoptotic cell death does not release these markers. 3

Overwhelmed Phagocytic Capacity

In many apoptotic areas, the phagocytic capacity becomes overwhelmed, resulting in large pools of apoptotic bodies lying free in the extracellular space. 3 This morphological progression from apoptosis to necrosis may depend upon exceeding the local capacity for phagocytosis of apoptotic cells. 3

References

Guideline

Myocardial Infarction Pathology

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Myocardial Infarction Pathophysiology and Coagulative Necrosis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Inflammation in cardiac injury, repair and regeneration.

Current opinion in cardiology, 2015

Research

Pathophysiology of Myocardial Infarction.

Comprehensive Physiology, 2015

Guideline

Myocardial Infarction Definition and Classification

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.